# The Health Protection (Notification) (Amendment) Regulations 2025

S.I. 2025/291 · made 5 March 2025

These Regulations amend the Health Protection (Notification) Regulations 2010 (“the Principal Regulations”).

Made under: Public Health (Control of Disease) Act 1984 (Section 45C, Section 45F, Section 45P)

PDFs: Printed copy https://openlegislation.uk/health-protection-notification-amendment-regulations-2025/pdf/uksi_20250291_en.pdf; UK Explanatory Memorandum https://openlegislation.uk/health-protection-notification-amendment-regulations-2025/pdf/uksiem_20250291_en_001.pdf

## Introductory text

PUBLIC HEALTH, ENGLAND
Made 5th March 2025
Laid before Parliament 7th March 2025
Coming into force 6th April 2025
The Secretary of State makes these Regulations in exercise of the powers conferred by sections 45C(1), (2) and (3)(a), 45F(2)(a) and (b), and 45P(2) of the Public Health (Control of Disease) Act 1984.
In accordance with section 45Q(3) of that Act, the Secretary of State is of the opinion that these Regulations do not contain any provision made by virtue of section 45C(3)(c) of the Act which imposes or enables the imposition of a special restriction or requirement or any other restriction or requirement which has or would have a significant effect on a person’s rights.

## 1 Citation, commencement, extent and application

(1) These Regulations may be cited as the Health Protection (Notification) (Amendment) Regulations 2025.
(2) These Regulations come into force on 6th April 2025.
(3) These Regulations extend to England and Wales and apply in relation to England only.

## 2 Amendment to the Health Protection (Notification) Regulations 2010

The Health Protection (Notification) Regulations 2010 are amended in accordance with regulations 3 to 5.

## 3 Amendment of regulation 4

In regulation 4 (duty on the operators of diagnostic laboratories to notify the United Kingdom Health Security Agency of causative agents found in human samples and of SARS-CoV-2 or influenza virus tests processed)—
(a) in the heading, after “SARS-CoV-2” insert “, respiratory syncytial virus”;
(b) in paragraph (1A)(b), after “of” insert “respiratory syncytial virus or”;
(c) in paragraph (2)(ba), after “SARS-CoV-2” insert “, respiratory syncytial virus”.

## 4 Amendment of Schedule 1

In Schedule 1 (Notifiable Diseases), at the appropriate alphabetical place insert—
Acute flaccid paralysis or acute flaccid myelitis (AFP or AFM)
Chickenpox (varicella)
Congenital syphilis
Creutzfeldt-Jakob disease (CJD)
Disseminated gonococcal infection (DGI)
Influenza of zoonotic origin
Middle East respiratory syndrome coronavirus (MERS)
Neonatal herpes

## 5 Amendment of Schedule 2

In Schedule 2 (Causative Agents), at the appropriate alphabetical place insert—
Candidozyma auris
Echinococcus spp
Middle East respiratory syndrome coronavirus (MERS-CoV)
Non-human influenza A subtypes
Norovirus
Respiratory syncytial virus (RSV)
Tick-borne encephalitis virus (TBEV)
Toxoplasma (congenital toxoplasmosis)
Trichinella spp
Yersinia spp

## Signature

Signed by the authority of the Secretary of State for Health and Social Care
Ashley Dalton
Parliamentary Under-Secretary of State
Department of Health and Social Care
5th March 2025

## Explanatory note

(This note is not part of the Regulations)
These Regulations amend the Health Protection (Notification) Regulations 2010 (“the Principal Regulations”).
Regulation 3 amends regulation 4 of the Principal Regulations to require diagnostic laboratories to notify the United Kingdom Health Security Agency of the results of the respiratory syncytial virus (RSV) tests which they process, including where the test result is indeterminate, negative or void.
Regulation 4 adds acute flaccid paralysis or acute flaccid myelitis (AFP or AFM), chickenpox (varicella), congenital syphilis, Creutzfeldt-Jakob disease (CJD), disseminated gonococcal infection (DGI), influenza of zoonotic origin, Middle East respiratory syndrome coronavirus (MERS) and neonatal herpes to the list of notifiable diseases in Schedule 1 to the Principal Regulations.
Regulation 5 adds candidozyma auris, echinococcus spp, Middle East respiratory syndrome coronavirus (MERS-CoV), non-human influenza A subtypes, norovirus, respiratory syncytial virus (RSV), tick-borne encephalitis virus (TBEV), toxoplasma (congenital toxoplasmosis), trichinella spp and yersinia spp to the list of causative agents in Schedule 2 to the Principal Regulations.
A full impact assessment of the effect that this instrument will have on the costs of business, the voluntary sector and the public sector is available from the Department of Health and Social Care, 39 Victoria Street, London, SW1H 0EU, which is available alongside this instrument on the legislation.gov.uk website.

---
Source: https://www.legislation.gov.uk/uksi/2025/291 (the official version)
Page: https://openlegislation.uk/health-protection-notification-amendment-regulations-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.